Human cytomegalovirus (HCMV) infects the majority of the population worldwide. As a member of the herpesvirus family, HCMV establishes in the infected individual a lifelong latent or persistent infection with the potential for reactivation. Reinfections with genetically different HCMV strains are also possible (8) . Fortunately, this infection usually remains clinically asymptomatic in immunocompetent individuals. However, in immunologically impaired hosts, such as transplant recipients, newborn infants, or patients with AIDS, HCMV can cause a wide spectrum of clinical syndromes (2) . In recent years, evidence has accumulated to suggest a role for HCMV in vascular alterations, such as rapidly progressive coronary artery disease, and endothelial alterations in cardiac transplant patients (14, 33) ; coronary artery restenosis after angioplasty (47, 57) ; and inflammatory aortic diseases (55) . Although these studies have suggested a role for HCMV in human vascular disease, there is still controversy (24, 35) .
Substantial evidence has implicated endothelial cells (EC) as natural hosts during HCMV infection (42) . HCMV immediate-early (IE) gene products have been identified during the latent state in EC, suggesting that these cells may be reservoirs for the maintenance of infection (12) . In addition, HCMV is capable of efficiently replicating in EC in vitro, provided the natural tropism of virus strains is conserved by serial passages in EC. The transmission of virus from EC to blood cells in cell culture models has underscored the emerging role of infected EC in the dissemination of virus (52) .
CD40 is a cell surface receptor that belongs to the tumor necrosis factor (TNF) receptor family and that was first identified and functionally characterized on B lymphocytes (5) . Its critical role in T-cell-dependent humoral immune responses was demonstrated in patients with the X-linked immunodeficiency hyperimmunoglobulin M (IgM) syndrome as well as by gene targeting in mice (15) . However, in recent years, it has become clear that the tissue distribution of CD40 is much broader and includes expression on monocytes, dendritic cells, epithelial cells, and EC (15, 49) . Thus, CD40 may play an important functional role in a wide spectrum of cells and tissues. The ligand for CD40, CD154, is a membrane-bound member of the TNF receptor family that is prominently expressed by activated CD4 ϩ T cells. In addition, CD154 has been found on mast cells, professional antigen-presenting cells, blood dendritic cells, NK cells, activated platelets, and EC at sites of inflammation (32, 50) . The critical role played by this ligand-receptor pair is underscored by the fact that its blockade globally inhibits humoral immunity and many aspects of cellular immunity (15) . Furthermore, the development and progression of a wide spectrum of autoimmune diseases as well as the response to transplantation antigens are halted upon therapeutic intervention with anti-CD154 antibodies (10, 26) . Increasing evidence supports the importance of CD40-CD154 interactions among EC, activated T cells, and circulating monocytes in atherosclerosis. CD40 is present on atheroma-derived cells in vitro and in human atheromata in situ (32) . Ligation of CD40 on atheroma-associated cells in vitro activates a number of processes responsible for lesion progression and plaque destabilization, such as the production of chemokines, cytokines, adhesion molecules, and tissue factors (31) . Inhibition of CD40-CD154 interactions by the administration of antibodies has been shown to reduce atherosclerosis in mice (30, 38) .
We examined the impact of HCMV infection on CD40 ex-pression by EC in vivo and in vitro. Our data reveal a considerable increase in CD40 levels on the surface of infected cultured EC between 8 and 96 h postinfection (p.i. 
MATERIALS AND METHODS
Cell cultures. Primary human umbilical vein EC (HUVEC) were obtained by chymotrypsin treatment of single umbilical vein cords and cultured in RPMI 1640 (Biochrom, Berlin, Germany) supplemented with 10% heat-inactivated (56°C, 45 min) HCMV-negative human serum, 5 U of heparin (Sigma, Deisenhofen, Germany)/ml, 50 g of EC growth factor (Becton Dickinson, Bedford, Mass.)/ml, and 100 mg of gentamicin/liter (complete RPMI). Human pulmonary artery EC (HPAEC) (Promocell, Heidelberg, Germany) were propagated in EBM-2 bullet kit medium (Clonetics, BioWhittaker Inc., Walkersville, Md.) containing 10% HCMV-negative human serum. HUVEC and HPAEC were grown in tissue culture material that had been precoated with 0.1% gelatin (Sigma) and were used between passages 2 and 6. The purity of HUVEC was confirmed by the presence of von Willebrand factor in Ͼ97% of the cells. Human foreskin fibroblasts (HFF) were grown as described previously (23) .
Viruses. The HCMV laboratory strain AD169 and the HCMV isolate TB40E (43) were harvested from the supernatants of infected HFF at 10 days p.i. by clarification at 500 ϫ g for 10 min, and aliquots were stored at Ϫ80°C. Virus stocks were titrated by using a plaque assay and were used at a multiplicity of infection (MOI) of 1 or 2. Virions were isolated by glycerol-tartrate gradient centrifugation (3) . For infection of HUVEC and HPAEC with HCMV, the medium was replaced with incomplete RPMI 1640 (without heparin and EC growth factor) for 1 h before virus inoculation. At 90 min after virus inoculation, the cells were washed twice with incomplete RPMI 1640. Complete RPMI or EBM-2 bullet kit medium was then added, and the cells were cultured for various time periods. Ganciclovir (Synthex Arzneimittel GmbH, Aachen, Germany) was present at 20 M (final concentration) throughout the entire culture period after infection. Cycloheximide (Sigma) at a final concentration of 150 g/ml was added to cell monolayers 30 min before viral or mock infection and left on the cells for 8 h after infection at 100 g/ml. The medium then was replaced with complete RPMI. In some experiments, 50 U of human TNF alpha (TNF-␣) (a gift from I. Strobel, Institute of Dermatology, University of Erlangen, Erlangen, Germany)/ml was added to the cells. The percentage of infected cells was determined by indirect immunofluorescence as described previously (23) . Infectious virus was neutralized with human monoclonal antibody C23 exactly as described previously (23) . To inactivate virus, stocks were placed in 1.5-ml Eppendorf reaction tubes and exposed to 254-nm UV light (40 W) for 1 h.
Antibodies. The following monoclonal antibodies or polyclonal sera were used: mouse IgG1-fluorescein isothiocyanate (FITC)-conjugated anti-human CD54 (Calbiochem, La Jolla, Calif.), anti-human major histocompatibility complex class I (MHC-I) (BD PharMingen, San Diego, Calif.), mouse IgG1-FITC antihuman CD40 (Dianova, Hamburg, Germany), mouse IgG1-FITC anti-human CD62E (Calbiochem), antibodies G28.5 and Ro1 (anti-human CD40) (gifts from H. Engelmann, Institute for Immunology, University of Munich, Munich, Germany) (39) , polyclonal rabbit anti-CD40 serum (Santa Cruz Biotechnology), rabbit antiserum against human calreticulin (Dianova), biotin-conjugated rabbit anti-mouse antibodies, and biotinylated swine anti-rabbit antibodies (Dako, Hamburg, Germany).
Flow cytometry. Mock-or HCMV-infected cell monolayers were treated with 0.5 mM EDTA in phosphate-buffered saline (PBS) for detachment from the flasks and were incubated with an FITC-phycoerythrin-conjugated specific antibody (4°C, 45 min). All antibody incubations were performed with PBS containing 5% fetal calf serum and 0.1% NaN 3 (FNCS/PBS). After incubation with the antibody, the cells were washed three times in FNCS/PBS and subsequently analyzed with a FACScalibur flow cytometer (Becton Dickinson, Heidelberg, Germany). Nonspecific fluorescence was assessed by staining the cells with irrelevant isotype-matched FITC-labeled monoclonal antibodies (BD PharMingen). A total of 5,000 gated events were collected and analyzed by using CellQuest software (BD PharMingen). For each treatment, the mean fluorescence intensity (MFI) of the control stained population was subtracted from the MFI of the positive stained sample. MFI values are geometric mean intensities and represent values normalized to the log scale, as calculated with CellQuest software.
Immunoblot analysis. Polyacrylamide gel electrophoresis and immunoblotting were performed by standard methods. Lysates from 1.5 ϫ 10 5 cells were analyzed per time point. Blots were developed by enhanced chemiluminescence according to the manufacturer's protocol (ECL Western detection kit; Amersham Pharmacia Biotech Europe, Freiburg, Germany). The levels of CD40 protein expression were normalized to that of a stable protein (calreticulin) by densitometric analysis with a scanner (UMAX PowerlookIII) and Aida 2.0 software (Raytest, Straubenhardt, Germany). For N-glycosidase F treatment, 7.5 ϫ 10 5 infected or mock-infected HUVEC were harvested per time point and resuspended in denaturing buffer (5% sodium dodecyl sulfate, 10% ␤-mercaptoethanol) at 100°C for 10 min. After the addition of 0.5 M sodium phosphate (pH 7.5), the solutions were divided into aliquots; one received 500 U of PNGase F (New England BioLabs, Schwalbach, Germany), and the other served as a control. Digestion was carried out for 3 h at 37°C and was terminated by the addition of 2ϫ sodium dodecyl sulfate sample buffer containing 10% ␤-mercaptoethanol.
RNA isolation and RT-PCR. Total RNA was prepared from infected and mock-infected HUVEC by using a High Pure RNA isolation kit (Roche, Mannheim, Germany). RNA preparations were digested with 10 U of DNase I (Amersham Pharmacia Biotech Europe) for 2 h at 37°C. The enzyme was inactivated by heating the samples to 60°C for 20 min. By use of a Titan One Tube reverse transcription (RT)-PCR system (Roche), cDNA was synthesized with 0.5 g of total RNA per reaction. RT was carried out at 58°C for 30 min. PCR was performed for 35 cycles at 94°C (30 s), primer annealing was performed at 50°C (30 s), and elongation was performed at 68°C (45 s; 5 s of extension per cycle) after a hot start.
The nucleotide sequences of primers were as follows: for human CD40, antisense, 5Ј-GGGACCACAGACAACATCAG-3Ј (nucleotides [nt] 611 to 592) (32) , and sense, 5Ј-TGCCAGCCAGGGACAGAAACT-3Ј (nt 168 to 187); for ICAM-1, sense, 5Ј-ACATGCAGCACCTCCTGTG-3Ј (nt 196 to 214) and antisense, 5Ј-CACCGTGGTCGTGACCTCAG-3Ј (nt 576 to 557); and for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), antisense, 5Ј-TCCACC ACCCTGTTGCTGTA-3Ј (nt 1037 to 1019) (48) , and sense, 5Ј-GTACGTCGT GGAGTCCACTG-3Ј (nt 339 to 358). The primers were obtained from ARK Scientific Biosystems (Darmstadt, Germany).
Controls in the absence of RT were included. Southern blot analysis of cDNA was carried out according to standard procedures. Probes consisting of the respective RT-PCR products were radioactively labeled with 32 P by using an NEBlot-kit (New England Biolabs, Beverly, Mass.). Signals were quantified by using a phosphorimager (bioimaging analyzer; Fuji, Tokyo, Japan) and appropriate software (Aida 2.0).
Immunohistochemical staining. For the analysis of CD40 expression in HCMV-infected tissues, simultaneous immunodetection of viral antigen and CD40 was performed with three-step immunoperoxidase staining and three-step immunoalkaline phosphatase staining, respectively. Formalin-fixed, paraffin-embedded tissue sections were deparaffinized and rehydrated. Endogenous peroxidase was blocked by incubation with 0.6% H 2 O 2 . Epitopes were unmasked by using Dako antigen retrieval solution according to the supplier's recommendations. Sections were then incubated with monoclonal antibody E13 directed against the IE proteins of HCMV (UL122/123; Biosoft, Paris, France), with biotinylated rabbit anti-mouse antibodies (Dako), and with streptavidin-biotinperoxidase complexes. Subsequent incubation with the chromogen diaminobenzidine (Sigma) yielded brown nuclear staining of HCMV-infected cells. Sections were then incubated with polyclonal rabbit serum directed against CD40, with biotinylated swine anti-rabbit antibodies (Dako), and with streptavidin-biotinalkaline phosphatase complexes. Subsequent incubation with the chromogen fast red (Sigma) resulted in red cytoplasmic staining. Sections were then counterstained with hematoxylin and mounted with glycerol-gelatin. Stained slides were analyzed under a Polyvar microscope. Specimens included samples from a congenitally infected child (one slide), a liver transplant patient (one slide), a patient with Crohn's disease (one slide), and human immunodeficiency virus-infected persons (three slides). Informed consent was obtained from the patient or a responsible family member.
The laboratory-adapted strains of HCMV that have been passaged for decades on human fibroblasts differ in at least two important aspects from recent clinical isolates: (i) they have lost the capacity to replicate to a significant extent in a number of cell types shown to be infected in vivo, including EC, and (ii) they lack approximately 15 kb of coding sequence (6) . To investigate the effect of HCMV infection in HUVEC, we therefore used the recently isolated HCMV strain TB40E. This virus strain replicates efficiently in a number of different human cell types, including fibroblasts and EC (43) .
HUVEC were infected at a multiplicity of infection of 1 or mock infected, and CD40 expression was determined at various times p.i. by indirect immunofluorescence flow cytometric (fluorescence-activated cell sorting [FACS] ) analysis. In general, Ͼ80% of cells were found to be infected at 24 h p.i. (data not shown). In accordance with published data, we observed a constitutive low level of expression of CD40 on uninfected HUVEC (21) (Fig. 1 ). This expression was maintained at similar levels over several early passages (3 to 6) (data not shown). Infection with TB40E drastically increased the expression of CD40 on the surface of HUVEC (Fig. 1A) . CD40 levels started to increase at 4 h p.i. and reached peak levels at 48 to 72 h p.i. Histograms for the FACS analysis at 2 and 48 h p.i. are shown in Fig. 1B . In repeated experiments, we observed an increase in CD40-specific MFI of between three-and fivefold in infected HUVEC. Increased expression of CD40 on the surface of infected cells was confirmed with a number of independent CD40-specific antibodies, including CD40-activating antibodies (data not shown) (39) . In contrast to the results obtained after infection of HUVEC with TB40E, no upregulation of CD40 was observed in fibroblasts (Fig. 1) . The addition of TNF-␣ to the culture medium resulted in the expected CD40 expression pattern, i.e., a slight increase on uninfected HUVEC but not on fibroblasts (Fig. 1A) . These results are consistent with previous reports (21, 54) . Control experiments analyzing the surface expression of MHC-I and ICAM-1 on HUVEC as well as fibroblasts gave results which were in agreement with published data (9, 18, 41, 53) . The expression of MHC-I was downregulated, whereas that of ICAM-1 was upregulated (Fig. 2) . Note that ICAM-1 surface expression on HUVEC differed from that of CD40 in that it started to increase between 24 and 48 h p.i. (Fig. 2, left panel) .
To test whether the observed upregulation of CD40 was also seen in EC from other sources, HPAEC were infected under conditions identical to those used for HUVEC, and CD40 expression levels were determined by FACS analysis. In re- peated experiments, we detected an increase in CD40 expression of between 1.5-and 2.5-fold after infection with TB40E, indicating that the upregulation of CD40 was a more general phenomenon associated with HCMV infection of EC (Table  1) . Binding of the CD40 ligand results in increased expression of E-selectin on infected HUVEC. The stimulation of CD40 by its ligand, CD154, results in the increased expression of adhesion molecules in EC (22) . To test whether HCMV infection can augment this process, we analyzed the expression of Eselectin (CD62E) following coculturing of HUVEC with Jurkat T-cell clone D1.1, expressing CD154, or Jurkat T-cell clone B2.7, which is negative for CD154 (28) . HUVEC were infected for 60 h with HCMV, cocultured with the respective Jurkat cells for 6 h, and analyzed for the expression of E-selectin by FACS analysis. As shown in Table 2 , E-selectin levels were comparable between infected and noninfected HUVEC, and coculturing with Jurkat T-cell clone B2.7 had no effect. Unchanged levels of E-selectin following HCMV infection of HUVEC have also been seen by others (41) . In contrast, a clear difference in E-selectin levels was seen in infected and noninfected HUVEC cocultured with CD154-expressing Jurkat cells. Infected HUVEC showed MFIs almost threefold higher than those of HUVEC cocultured with CD154-negative Jurkat cells. The elevated levels of E-selectin seen in noninfected HUVEC cocultured with Jurkat T-cell clone D1.1 were most probably due to the stimulation of CD40 constitutively expressed by these cells (as demonstrated in Fig. 1 ). As expected, the addition of TNF-␣ to HUVEC resulted in a drastic increase in E-selectin expression in both infected and noninfected HUVEC (Table 2) .
Adsorption and penetration of virions are insufficient events for the upregulation of CD40. The binding of HCMV virion envelope molecules to the plasma membrane of target cells has been reported to rapidly upregulate cellular transcription factors, such as Sp-1 and NF-B which, in turn, could potentially activate CD40 transcription (56) . We therefore next investigated whether the observed CD40 upregulation was related to the initial physical interaction between the virus and the target cell. First, we used UV-inactivated virus to determine the effect on CD40 expression. No upregulation of CD40 was seen when UV-inactivated virions were used for infection (data not shown). Next, the human anti-HCMV monoclonal antibody C23 was used to neutralize the infectivity of TB40E. This antibody allows the attachment of virions to cells but inhibits the penetration of viral particles into target cells (34) . A total of 10 6 PFU of TB40E virions were incubated with C23 for 4 h, and the mixture was used to infect HUVEC. This treatment resulted in 100% neutralization of viral infectivity (data not shown). The upregulation of CD40 was completely inhibited following the neutralization of virus (Fig. 3, left panel) . Whether the penetration of virions into HUVEC contributed to the CD40 upregulation was tested with HCMV strain AD169. Although laboratory-adapted HCMV strain AD169 replicates inefficiently in EC, it can attach to and penetrate these cells at rates comparable to those for fibroblasts (44) . We therefore used this experimental tool to test whether events following adsorption, such as fusion between viral and cellular membranes and/or penetration of target cells, were involved in CD40 upregulation. As shown in Fig. 3 , CD40 expression levels remained unchanged after HUVEC infection with strain AD169. Taken together, these data indicate that adsorption and penetration of HCMV virions are insufficient for the upregulation of CD40 expression on EC.
De novo protein synthesis is required for the upregulation of CD40 on infected HUVEC. The above results suggested that events following viral penetration are required for the upregulation of CD40. To analyze whether de novo protein synthesis was necessary for the observed effect, we infected HUVEC in the presence of cycloheximide. Cells were treated with the drug during the first 8 h of infection. No increase in CD40 levels was seen in the cultures during that period, whereas control cultures showed the expected upregulation of CD40 (Fig. 4) . Removal of the cycloheximide block at 8 h p.i. resulted in an increase in CD40 levels to values comparable to those in control cultures at 48 and 72 h p.i. In contrast, treatment of cells with ganciclovir, an inhibitor of viral DNA synthesis, allowed CD40 upregulation with kinetics identical to those in infected cells not treated with the drug (Fig. 4) . Thus, de novo protein synthesis is essential for the enhanced expression of CD40 in infected EC.
CD40 mRNA and protein levels remain constant during early times after HCMV infection. Next, we investigated whether the cell surface expression of CD40 molecules on infected HUVEC was paralleled by an increase in the total CD40 protein level. Cells were infected for 0 to 96 h with TB40E, and lysates were prepared and subjected to immunoblot analysis with a polyclonal rabbit serum against CD40. Signals were obtained at 45 kDa, which is in agreement with the reported molecular mass of CD40 (Fig. 5A) . Following infection, the signal intensity remained constant at 0 to 24 h p.i. and was clearly enhanced at 48 to 96 h p.i. The increase at later times p.i. was accompanied by the presence of slower-migrating forms of CD40 beginning at 72 h p.i. (Fig. 5A) . A slight increase in the CD40 protein level was also seen in mockinfected HUVEC at 72 and 96 h. Levels of calreticulin, an endoplasmic reticulum-resident protein, remained constant over the entire observation period in both infected and mockinfected cells (Fig. 5B) . Densitometric evaluation of the signals obtained on immunoblots confirmed the constant level of CD40 between 0 and 48 h p.i. as well as an approximately threefold increase in the level in infected cells at later times (Fig. 5C ). To test whether the slower-migrating proteins which were synthesized late after infection represented CD40, cell lysates were treated with endoglycosidase F prior to immuno- Fig. 5D , all forms of the antibody-reactive protein could be converted to the 40-kDa nonglycosylated form of CD40, indicating that the slower-migrating proteins represented CD40. To investigate whether mRNA levels for CD40 paralleled increased protein levels, we analyzed the mRNA concentrations for CD40 in infected and mock-infected HUVEC by using RT-PCR. The amplification of total mRNA with CD40-specific primers revealed products of the expected size (443 bp) (Fig. 6A) . Genomic contamination was excluded by the absence of a product following PCR of non-reverse-transcribed mRNA preparations (data not shown). The RT-PCR products were subjected to Southern blot analysis with 32 Plabeled CD40 cDNA as a probe. Signals were collected by phosphorimaging. As an internal control, mRNA specific for GAPDH was amplified together with CD40 and probed with the respective radiolabeled cDNA fragment (Fig. 6B) . In general, CD40 mRNA levels showed kinetics identical to those found for CD40 protein levels, i.e., a constant level at early times p.i. (0 to 8 h) followed by a slight increase at later times (24 to 72 h) (Fig. 6 ). Signal quantification after phosphorimaging revealed that at 72 h p.i., relative to GAPDH expression, CD40 mRNA levels were 1.3-to 1.5-fold higher in infected HUVEC than in noninfected HUVEC (data not shown). In agreement with previously published data, we observed a 4-to 5.8-fold increase in ICAM-1 mRNA levels at 24 and 48 h p.i. (Fig. 6) (4) .
HCMV-infected EC express elevated levels of CD40 in vivo.
To analyze the expression of CD40 in HCMV-infected EC in vivo, immunohistochemical staining of tissue sections from patients with acute HCMV pneumonitis and gastroenteritis was performed. Viral IE antigen and CD40 were simultaneously detected by indirect immunoperoxidase staining and indirect alkaline phosphatase staining, respectively. With this approach, three patterns of antigen expression were revealed. (i) In general, foci of HCMV-infected cells were surrounded by an inflammatory reaction, and within such foci of inflammation, enhanced CD40 expression was detectable (Fig. 7A and C) . This finding was mainly due to infiltration of CD40-positive monocytes. In addition, moderate CD40 expression was detectable on endothelial layers within such foci of infection. 
CD3
ϩ T cells were also present in the surrounding infected vessels, with CD40 upregulation (data not shown). (ii) With regard to CD40 expression on HCMV-infected EC, the majority of infected EC showed moderate CD40 signals comparable to those shown by adjacent uninfected cells (Fig. 7B) . (iii) However, on a fraction of infected cells, overexpression of CD40 relative to that seen on adjacent uninfected cells occurred (Fig. 7D) . In total, 42 infected EC were detected on six slides from different patients. Eight (19%) were negative for CD40, 17 (40%) expressed moderate CD40 levels, and 17 (40%) showed markedly enhanced CD40 levels. Various other surface molecules were expressed differently on infected EC. In contrast to the upregulation observed with CD40, the expression of VCAM-1 was unaltered, and MHC-I molecules were downregulated (data not shown). Enhanced CD40 signals were found on HCMV-infected EC with or without nuclear inclusions, indicating that this effect may occur early in the infectious cycle of HCMV. This effect seemed to be cell type specific, as CD40 induction was never observed in HCMVinfected epithelial cells (Fig. 7E) .
DISCUSSION
EC represent a major target for HCMV. In vivo studies showed that EC are frequently infected in a variety of organs (42) . Moreover, the appearance of HCMV-infected EC in peripheral blood of patients demonstrates vascular injury following HCMV infection (36) . In vitro experiments with HCMVinfected EC have revealed a number of different effects which could negatively affect EC function and/or induce inflammatory reactions (40, 41) . Given the essential role of the endothelium for many physiological processes, it can be expected that infection of EC with HCMV in vivo will have profound effects on EC-associated pathology.
Our data clearly show that the expression of CD40 on the surface of EC is enhanced following infection with HCMV and that subsequent stimulation by CD154 activates EC to express adhesion molecules. The increase in CD40 expression was specific for EC infected with an HCMV isolate which can efficiently replicate in these cells. Infection of fibroblasts had no effect on the expression of CD40. Likewise, infection of EC with HCMV isolates that penetrate well but replicate inefficiently in these cells did not alter CD40 expression. Interestingly, the data suggested that the increased expression of CD40 on the surface of EC was mediated by more than one mechanism. During the early phase p.i. (8 to 24 h), increased expression of CD40 on the surface of EC was observed in FACS analyses. However, this increase was not accompanied by elevated concentrations of CD40 protein in whole-cell lysates. Likewise, CD40 mRNA levels remained constant during this period. In contrast, elevated protein and mRNA levels were seen at late times p.i. (48 to 96 h) .
The in vitro findings were confirmed by immunohistochemical analyses of HCMV-infected tissue sections. In a significant fraction of infected EC, increased levels of CD40 were observed. The fact that not all infected EC showed enhanced CD40 staining was most probably related to the state of infection in individual cells. Since at an early stage of infection the increase in CD40 levels on the surface of EC is not accompanied by an increase in overall protein levels, such cells will not stain more intensely than noninfected EC. Only the fraction of cells at a late stage of infection will contain elevated levels of CD40 and stain more prominently. The immunohistochemical analyses also confirmed the cell type specificity of the upregu- In no case did we detect infected epithelial cells that contained enhanced CD40 levels, although these cells are capable of expressing CD40 (49) . Moreover, the in vivo detection of elevated CD40 levels in tissues from different donors suggested that the upregulation of this molecule was not secondary to tissue culture adaptation of our HCMV isolate to EC. HCMV has the potential to alter cellular gene expression through multiple mechanisms. Physical interactions of viral surface glycoproteins with target cells can result in changes in cellular transcription factors and immunoregulatory molecule expression (56) . Also, constituents of virions, such as tegument protein pp71, migrate to the nucleus and activate transcription after infection (29) . These mechanisms were not operative in the upregulation of CD40 at early times after infection. This conclusion can be drawn from experiments in which (i) adsorption of virus was allowed but penetration was inhibited by antibodies; (ii) UV-inactivated virus was used for infection; and (iii) HCMV strain AD169, which efficiently penetrates EC but replicates poorly, was used. In no case were elevated levels of CD40 seen on infected EC. Instead, de novo protein synthesis was shown to be essential for the early upregulation of CD40.
Although we have no formal proof at the moment, the upregulation of CD40 as early as 6 to 8 h p.i. strongly suggests the participation of viral IE proteins. Transcription of IE genes occurs immediately after entry of the virus into the host cell. We were able to detect IE proteins between 2 and 4 h after infection of EC (data not shown). HCMV encodes a number of IE proteins which could be involved in the upregulation of CD40 expression. Only a fraction of these proteins have been functionally analyzed. The best-characterized proteins are IE1 and IE2. They represent nuclear proteins which modulate the transcription of a number of viral and cellular promoters (13) . Particularly relevant for the interpretation of our data is the fact that the IE1 and IE2 proteins synergistically activate ICAM-1 gene expression, which results in an increase in ICAM-1 mRNA levels following infection (4) . The increase in ICAM-1 protein levels in our experiments was also accompanied by a parallel increase in ICAM-1 mRNA levels (data not shown). However, the kinetics of expression of ICAM-1 on the surface of infected cells differed significantly from those of CD40. Whereas increased CD40 concentrations on the surface of EC were detected between 6 and 8 h p.i., ICAM-1 levels started to increase between 24 and 48 h p.i. Moreover, characteristically for transactivation through IE1 and IE2 proteins, the upregulation of ICAM-1 gene expression is independent of the cell type and can also be seen in fibroblasts (16; this work). Thus, the available data suggest that the upregulation of CD40 at early times after infection may be mediated by mechanisms other than direct transactivation via the IE1 and IE2 proteins.
Apart from the IE1 and IE2 proteins, HCMV strain AD169 codes for a number of additional IE proteins (7). Uncharacteristically for human herpesviruses, several of these IE proteins are type I integral membrane glycoproteins, suggesting a potential role in cellular transport mechanisms. Moreover, recent clinical isolates that effectively infect EC carry a number of additional glycoprotein genes whose temporal expression patterns have not yet been explored (6) . With respect to already characterized IE proteins from strain AD169, it is interesting that IE protein US3 is known to bind and retain MHC-I heavy chains in the endoplasmic reticulum, thereby inhibiting antigen presentation (19) . Another example of an IE glycoprotein is US37, a glycoprotein which travels through the secretory pathway to the plasma membrane (1) . Thus, it is tempting to speculate that IE glycoproteins may be involved in the early appearance of enhanced CD40 levels on the surface of infected EC. No matter what the underlying mechanism is, currently available antiviral drugs, such as ganciclovir, were unable to inhibit the effect. The mechanism for the increase in CD40-specific mRNA and protein levels at late times after infection is also unknown at present. However, it is well documented that HCMV, unlike other herpesviruses, is capable of stimulating host cell macromolecule synthesis throughout the entire infection cycle.
What might be the relevance of our findings for the in vivo situation? HCMV infection has been linked to a number of pathological situations resulting from alterations of the endothelium, in particular, transplantation-associated vasculopathy, restenosis after angioplasty, and atherosclerosis (11, 25, 45, 46) . Transplantation-associated vasculopathy has emerged as a major limitation to long-term graft survival in transplantation (20) . A number of reports have implicated HCMV as an aggravating agent in the development of transplantation-associated vasculopathy (17, 25) . The findings were also supported by animal studies (27) . Our data suggest a potential pathogenic role for HCMV infection in transplantation-associated vasculopathy. As we have shown here, HCMV infection will lead to increased CD40 levels on EC. Chronically activated alloreactive T cells carrying CD154 can bind to EC and lead to further activation of EC, manifested by the expression of elevated levels of adhesion molecules, such as E-selectin and ICAM-1. The presence of E-selectin and ICAM-1, both critical mediators of leukocyte recruitment, will result in enhanced adhesion of leukocytes. On the other hand, T cells will also be stimulated to produce proinflammatory cytokines, such as gamma interferon and TNF-␣. In fact, it was shown that HCMV-infected EC are capable of directly eliciting vigorous activation responses by T cells and that these T cells produce interleukin 2, TNF-␣, and gamma interferon (51) . Thus, the total effects mediated by infection of EC by HCMV clearly have the potential to exacerbate transplantation-associated vasculopathy. Interestingly, HCMV also seems to be capable of upregulating CD40 on dentritic cells, a cell population that also interacts with T cells (37) .
In conclusion, we have shown that HCMV infection results in rapid and sustained upregulation of CD40 on the surface of EC. The effect is specific, since neither fibroblasts (infected in vitro) nor epithelial cells (infected in vivo) showed increased levels of CD40. Considering the widespread distribution of HCMV in humans, CD40 upregulation could represent an important factor contributing to the development of vascular alterations, such as transplantation-associated vasculopathy or atherosclerosis. Further efforts will be directed toward studying the mechanism of CD40 upregulation by HCMV.
